Trump Administration Considers Tying US Drug Prices to International Benchmarks
Reuters reported that the Trump administration is exploring a policy to tie domestic drug prices...
Policy / Regulatory
NMPA Issues 91st Batch of Reference Standards for Generic Drug Quality Evaluation
The National Medical Products Administration (NMPA) has released the 91st batch of reference standards for...
China’s Medical Insurance Payment Reform Achieves Nationwide Coverage, Faces Challenges Ahead
The first blue book on the reform of China’s medical insurance payment methods, titled “Report...
Shanghai Healthcare Administration Pushes for 11th Round of VBP
Shanghai’s Healthcare Security Administration (HSA) bureau held a work conference on April 16, 2025, to...
Trump Orders HHS to Reduce Drug Prices, Revamp Medicare Negotiation Program
President Donald Trump issued a new Executive Order aimed at reducing drug prices for American...
NHC Releases Standardized Family Doctor Service Packages for Key Demographic Groups
The National Health Commission (NHC) has issued the “List of Basic Service Packages for Family...
US Commerce Department Launches Section 232 Probe on Pharma Imports and National Security
The US Department of Commerce (DoC) has initiated a Section 232 investigation to evaluate the...
NHC Urges Hospitals to Establish Healthy Weight Management Clinics by June
The National Health Commission (NHC) has issued a notification encouraging eligible Class 3 general hospitals,...
U.S. Tariffs on Pharmaceuticals and Their Impact on China’s Medical Industry
The U.S. administration’s decision to impose tariffs on pharmaceutical imports, effective April 9, has sent...
NMPA Optimizes Drug Manufacturing License Process with Digital QR Codes
The National Medical Products Administration (NMPA) has announced new measures to optimize the drug manufacturing...
Shenzhen Unveils Comprehensive Policy Package to Boost Biopharma Innovation
Shenzhen has launched an ambitious policy package, “Several Measures to Support Pharmaceuticals and Medical Devices...
Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency
The Beijing Municipal Medical Insurance Bureau, in collaboration with seven other bureaus, has released the...
NMPA Reduces Influenza Vaccine Batch Release Time to 45 Working Days
The National Medical Products Administration (NMPA) has issued a notification reducing the time limit for...
China’s National Health Commission Outlines Key Tasks for Primary Healthcare Reform in 2025
The General Office of China’s National Health Commission has issued a notice outlining key tasks...
China Proposes New Measures to Optimize High-End Medical Device Regulation
The National Medical Products Administration (NMPA) has released the “Measures for Optimizing Full Lifecycle Supervision...
NHC Data Reveals Digital Leap for Class 3 Hospitals Amid Drug Cost Crackdown
China’s 2,168 Class 3 public hospitals demonstrated enhanced fiscal discipline in 2023, with medical services...
China’s IAC Drafts Commercial Health Insurance Drug List A-Series to Bridge NRDL Coverage Gaps
The Insurance Association of China (IAC) has unveiled its inaugural draft for the Commercial Health...
China Scraps Outpatient Prepayment in Public Hospitals by 2025: Healthcare Reform Shifts Financial Burden
The National Health Commission (NHC) will eliminate outpatient prepayment requirements across public medical institutions by...
China Tightens Medical Device Quality Oversight: 2025 Inspection Plan Unveiled
China’s National Medical Products Administration (NMPA) has released its 2025 medical device inspection plan, outlining...
Policy Analysis: Shanghai’s 2025 Pharmaceutical Procurement Regulation and Market Implications
Shanghai’s Medical Centralized Bidding and Procurement Affairs Management Office has released its January 2025 list...